The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.
Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications
Abstract
Background Postmortem and in vivo imaging data support the hypothesis that premature myelin breakdown and subsequent homeostatic remyelination attempts with increased oligodendrocyte and iron levels may contribute to Huntington's Disease (HD) pathogenesis and the symmetrical progress of neuronal loss from earlier-myelinating striatum to later-myelinating regions. A unique combination of in vivo tissue integrity and iron level assessments was used to examine the hypothesis.Methods A method that uses two Magnetic resonance imaging (MRI) instruments operating at different field-strengths was used to quantify the iron content of ferritin molecules (ferritin iron) as well as tissue integrity in eight regions in 11 HD and a matched group of 27 healthy control subjects. Three white matter regions were selected based on their myelination pattern (early to later-myelinating) and fiber composition. These were frontal lobe white matter (Fwm) and splenium and genu of the corpus callosum (Swm and Gwm). In addition, gray matter structures were also chosen based on their myelination pattern and fiber composition. Three striatum structures were assessed [caudate, putamen, and globus pallidus (C, P, and G)] as well as two comparison gray matter regions that myelinate later in development and are relatively spared in HD [Hippocampus (Hipp) and Thalamus (Th)].Results Compared to healthy controls, HD ferritin iron levels were significantly increased in striatum C, P, and G, decreased in Fwm and Gwm, and were unchanged in Hipp, Th, and Swm. Loss of tissue integrity was observed in C, P, Fwm, and especially Swm but not Hipp, Th, G, or Gwm. This pattern of findings was largely preserved when a small subset of HD subjects early in the disease process was examined.Conclusions The data suggest early in the HD process, myelin breakdown and changes in ferritin iron distribution underlie the pattern of regional toxicity observed in HD. Prospective studies are needed to verify myelin breakdown and increased iron levels are causal factors in HD pathogenesis. Tracking the effects of novel interventions that reduce myelin breakdown and iron accumulation in preclinical stages of HD could hasten the development of preventive treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in brain iron metabolism with increased iron accumulation were identified by MRI in the striata of patients with Huntington’s disease194 and in particular the basal ganglia (caudate nucleus, putamen, and globus pallidus).195,196”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [194]
Citations
Cites
Tests for comparing elements of a correlation matrix
Steiger, J. H. (1980) · Psychological Bulletin · doi:10.1037/0033-2909.87.2.245 · Cited by 4,621 · cited 1×
“were performed using Hotelling’s statistic [60], a test for the difference between two non-independent correlations [61].”
MethodWalker, F. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60111-1 · Cited by 2,691
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Regional Development of the Brain in Early Life
(1968) · Archives of Disease in Childhood · doi:10.1136/adc.43.229.388 · Cited by 2,107
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Vonsattel, J. P., & DiFiglia, M. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199805000-00001 · Cited by 1,305
Gauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968
Self-citationIntramuscular desferrioxamine in patients with Alzheimer's disease
MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764
LINGO-1 negatively regulates myelination by oligodendrocytes
Mi, S., Miller, R. H., Lee, X., Scott, M. L., Shulag-Morskaya, S., Shao, Z., Chang, J., Thill, G., Levesque, M., Zhang, M., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1460 · Cited by 628
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain
Sapp, E., Kegel, K. B., D, N. A. M., Hashikawa, T., Uchiyama, Y., Tohyama, K., Bhide, P. G., Vonsattel, J., & DiFiglia, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.2.161 · Cited by 558
Evidence for more widespread cerebral pathology in early HD
Rosas, H. D., Koroshetz, W. J., Chen, Y. I., Skeuse, C., Vangel, M. G., Cudkowicz, M., Caplan, K., MAREK, K. L., Seidman, L. J., Makris, N., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000065888.88988.6e · Cited by 512
Huntingtin and the molecular pathogenesis of Huntington's disease
Landles, C., & Bates, G. P. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400250 · Cited by 496
The regional distribution and cellular localization of iron in the rat brain
Hill, J. M., & Switzer, R. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90046-0 · Cited by 486
Microglial activation correlates with severity in Huntington disease: A clinical and PET study
Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000222734.56412.17 · Cited by 462 · cited 1×
“HD pathology is associated with increased microglia numbers and their activation [78, 79], however, although”
Backgroundde la Monte, S. M., Vonsattel, J., & Richardson, E. P. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198809000-00003 · Cited by 444
Hotelling, H. (1940) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177731867 · Cited by 436
Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey
LaMantia, A., & RAKIC, P. T. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902910404 · Cited by 428
Bartzokis, G., Sultzer, D., Lu, P. H., Nuechterlein, K. H., Mintz, J., & Cummings, J. L. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.09.005 · Cited by 363
Self-citation(2010) · Oxford University Press eBooks · doi:10.1093/med/9780195369298.001.0001 · Cited by 360
Canals, J. M., Pineda, J. R., Torres-Peraza, J. F., Bosch, M., Martín‐Ibáñez, R., Muñoz, M. T., Mengod, G., Ernfors, P., & Alberch, J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1197-04.2004 · Cited by 345
Neurobiological Bases of Age-Related Cognitive Decline in the Rhesus Monkey
Peters, A., Rosene, D. L., Moss, M. B., Kemper, T. L., Abraham, C. R., Tigges, J., & Albert, M. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199608000-00001 · Cited by 344
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration
Bartzokis, G., Tishler, T. A., Lu, P. H., Villablanca, P. J., Altshuler, L. L., Carter, M., Huang, D., Edwards, N. J., & Mintz, J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.005 · Cited by 343
Self-citationIron misregulation in the brain: a primary cause of neurodegenerative disorders
Ke, Y., & Qian, Z. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00353-3 · Cited by 341
OʼKusky, J. R., & Colonnier, M. (1982) · The Journal of Comparative Neurology · doi:10.1002/cne.902100307 · Cited by 335
Quintana, C., Bellefqih, S., Laval, J. Y., Guerquin‐Kern, J., Wu, T., Ávila, J., Ferrer, I., Arranz, R., & Patiño, C. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.11.001 · Cited by 297
Dexter, D. T., Jenner, P. G., Schapira, A. H. V., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320716 · Cited by 292
Poser, C. M. (1995) · JAMA · doi:10.1001/jama.1995.03520280102058 · Cited by 284
The distribution of structural neuropathology in pre-clinical Huntington's disease
Thieben, M. J. (2002) · Brain · doi:10.1093/brain/awf179 · Cited by 270
Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus
Myers, R. H., Vonsattel, J. P., Paskevich, P. A., Kiely, D. K., Stevens, T. J., Cupples, L. A., Richardson, E. P., & Bird, E. D. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00005 · Cited by 239
Brain Structure in Preclinical Huntington’s Disease
Paulsen, J. S., Magnotta, V. A., Mikos, A., Paulson, H. L., Penziner, E., Andreasen, N. C., & Nopoulos, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.003 · Cited by 236
In Vivo Evaluation of Brain Iron in Alzheimer Disease Using Magnetic Resonance Imaging
Bartzokis, G., Sultzer, D. L., Cummings, J. L., Holt, L. E., Hance, D. B., Henderson, V. W., & Mintz, J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.47 · Cited by 235
Self-citationYOUDIM, M. B. H., STEPHENSON, G., & SHACHAR, D. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.025 · Cited by 233
Role of Iron in Neurodegenerative Disorders
Berg, D., & Youdim, M. B. H. (2006) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000245461.90406.ad · Cited by 228
MRI evaluation of brain iron in earlier- and later-onset Parkinson’s disease and normal subjects
Bartzokis, G., Cummings, J. L., Markham, C. H., Marmarelis, P. Z., Treciokas, L. J., Tishler, T. A., Marder, S. R., & Mintz, J. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00155-6 · Cited by 219
Self-citationHistochemical Distribution of Non-Haem Iron in the Human Brain
Morris, C. M., Candy, J., Oakley, A. E., Bloxham, C. A., & Edwardson, J. A. (1992) · Cells Tissues Organs · doi:10.1159/000147312 · Cited by 218
Cellular management of iron in the brain
Connor, J. R., & Menzies, S. L. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00206-h · Cited by 214
Morphometric analysis of the prefrontal cortex in Huntington's disease
Sotrel, A., Paskevich, P. A., Kiely, D. K., Bird, E. D., Williams, R. S., & Myers, R. H. (1991) · Neurology · doi:10.1212/wnl.41.7.1117 · Cited by 204
Current Status of Metals as Therapeutic Targets in Alzheimer's Disease
Finefrock, A. E., Bush, A. I., & Doraiswamy, P. M. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51368.x · Cited by 203
Cerebral structure on MRI, part II: Specific changes in Alzheimer's and Huntington's diseases
Jernigan, T. L., Salmon, D. P., Butters, N., & Hesselink, J. R. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90211-4 · Cited by 198
Nguyen, T., Hamby, A., & Massa, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502177102 · Cited by 194
Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases
Bartzokis, G., Tishler, T. A., Shin, I., Lu, P. H., & Cummings, J. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.019 · Cited by 184
Self-citationIncreased basal ganglia iron levels in Huntington disease
Bartzokis, G., Cummings, J., Perlman, S., Hance, D. B., & Mintz, J. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.569 · Cited by 183
Self-citationMR evaluation of age-related increase of brain iron in young adult and older normal males
Bartzokis, G., Beckson, M., Hance, D. B., Marx, P., Foster, J., & Marder, S. R. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(96)00234-2 · Cited by 181
Self-citationSchizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation
Bartzokis, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00364-0 · Cited by 179
Self-citationIron regulation in the brain: Histochemical, biochemical, and molecular considerations
Connor, J. R., & Benkovic, S. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320710 · Cited by 177
Quantitative neuropathological changes in presymptomatic Huntington's disease
Gómez‐Tortosa, E., MacDonald, M. E., Friend, J. C., Taylor, S. A., Weiler, L., Cupples, L. A., Srinidhi, J., Gusella, J. F., Bird, E. D., Vonsattel, J., et al. (2001) · Annals of Neurology · doi:10.1002/1531-8249(200101)49:1 · Cited by 174
The relation between brain iron and NMR relaxation times: An in vitro study
Vymazal, J., Brooks, R. A., Baumgarner, C. D., Tran, V., Katz, D., Bulte, J. W. M., Bauminger, E. R., & Chiro, G. D. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910350108 · Cited by 172
Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores
Bartzokis, G., Aravagiri, M., Oldendorf, W. H., Mintz, J., & Marder, S. R. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910290406 · Cited by 172
Self-citationFrontal lobe volume in patients with Huntington's disease
Aylward, E., Anderson, N. B., Bylsma, F., Wagster, M. V., Barta, P. E., Sherr, M., Feeney, J., Davis, A., Rosenblatt, A., Pearlson, G. D., et al. (1998) · Neurology · doi:10.1212/wnl.50.1.252 · Cited by 170
In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease
Fennema‐Notestine, C., Archibald, S. L., Jacobson, M. W., Corey‐Bloom, J., Paulsen, J. S., Peavy, G. M., Gamst, A. C., Hamilton, J. M., Salmon, D. P., & Jernigan, T. L. (2004) · Neurology · doi:10.1212/01.wnl.0000138434.68093.67 · Cited by 168
Metals in our minds: therapeutic implications for neurodegenerative disorders
Doraiswamy, P. M., & Finefrock, A. E. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00809-9 · Cited by 161
Cellular iron status influences the functional relationship between microglia and oligodendrocytes
Zhang, X., Surguladze, N., Slagle‐Webb, B., Cozzi, A., & Connor, J. R. (2006) · Glia · doi:10.1002/glia.20416 · Cited by 160
Chen, J. C., Hardy, P., Kucharczyk, W., Clauberg, M., Joshi, J. G., Vourlas, A., Dhar, M. S., & Henkelman, R. M. (1993) · PubMed Central · Cited by 156
Oligodendrocytes, their Progenitors and other Neuroglial Cells in the Aging Primate Cerebral Cortex
Peters, A. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh060 · Cited by 152
Reading, S. A. J., Yassa, M. A., Bakker, A., Dziorny, A. C., Gourley, L. M., Yallapragada, V., Rosenblatt, A., Margolis, R. L., Aylward, E., Brandt, J., et al. (2005) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2005.05.011 · Cited by 151
Hartman, B. K., Agrawal, H. C., Agrawal, D., & Kalmbach, S. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.13.4217 · Cited by 151
In vivo MR evaluation of age-related increases in brain iron.
Bartzokis, G., Mintz, J., Sultzer, D. L., Marx, P., Herzberg, J., Phelan, C., & Marder, S. R. (1994) · PubMed Central · Cited by 140
Self-citationIn vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI
Bartzokis, G., Sultzer, D. L., Mintz, J., Holt, L. E., Marx, P., Phelan, C., & Marder, S. R. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90047-7 · Cited by 137
Self-citationApolipoprotein E Genotype and Age-Related Myelin Breakdown in Healthy Individuals
Bartzokis, G., Lu, P. H., Geschwind, D. H., Edwards, N. J., Mintz, J., & Cummings, J. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.63 · Cited by 134
Self-citationDjalali, S., Höltje, M., Große, G., Rothe, T., Stroh, T., Große, J., Deng, D. R., Hellweg, R., Grantyn, R., Hörtnagl, H., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02911.x · Cited by 130
Mann, D. M. A., Oliver, R., & Snowden, J. S. (1993) · Acta Neuropathologica · doi:10.1007/bf00230496 · Cited by 127
Kamman, R. L., Go, K. G., Brouwer, W., & Berendsen, H. J. C. (1988) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910060304 · Cited by 117
Nicotine's oxidative and antioxidant properties in CNS
Newman, M. B., Arendash, G. W., Shytle, R. D., Bickford, P. C., Tighe, T., & Sanberg, P. R. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02135-5 · Cited by 116
Huntington Disease: Volumetric, Diffusion-weighted, and Magnetization Transfer MR Imaging of Brain
Mascalchi, M., Lolli, F., Nave, R. D., Tessa, C., Petralli, R., Gavazzi, C., Politi, L. S., Macucci, M., Filippi, M., & Piacentini, S. (2004) · Radiology · doi:10.1148/radiol.2322030820 · Cited by 114
Regionally Specific Effects of BDNF on Oligodendrocytes
Du, Y., Fischer, T. Z., Lee, L. N., Lercher, L. D., & Dreyfus, C. F. (2003) · Developmental Neuroscience · doi:10.1159/000072261 · Cited by 113
Huntington and its Role in Neuronal Degeneration
Li, S., & Li, X. (2004) · The Neuroscientist · doi:10.1177/1073858404266777 · Cited by 111
Iron in Brain Function and Dysfunction with Emphasis on Parkinson’s Disease
Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (2008) · European Neurology · doi:10.1159/000116719 · Cited by 105
Bulte, J. W. M., Miller, G., Vymazal, J., Brooks, R. A., & Frank, J. A. (1997) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910370409 · Cited by 98
Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders
Bartzokis, G. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.001 · Cited by 97
Self-citationIron‐enriched oligodendrocytes: A reexamination of their spatial distribution
LeVine, S. M., & Macklin, W. B. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490260415 · Cited by 91
Tolwani, R. J., Cosgaya, J. M., Varma, S., Jacob, R., Kuo, L. E., & Shooter, E. M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20181 · Cited by 90
Magnetic resonance imaging of brain iron in health and disease
Vymazal, J., Brooks, R. A., Patronas, N. J., Hájek, M., Bulte, J. W. M., & Chiro, G. D. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00204-f · Cited by 88
Shin, R., Kruck, T. P. A., Murayama, H., & Kitamoto, T. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03893-3 · Cited by 88
Vymazal, J., Hájek, M., Patronas, N., Giedd, J. N., Bulte, J. W. M., Baumgarner, C. D., Tran, V., & Brooks, R. A. (1995) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880050514 · Cited by 87
T1 and T2 of ferritin solutions: Effect of loading factor
Vymazal, J., Zak, O., Bulte, J. W. M., Aisen, P., & Brooks, R. A. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910360111 · Cited by 84
Differential Expression of Normal and Mutant Huntington's Disease Gene Alleles
Persichetti, F., Carlée, L., Faber, P. W., McNeil, S. M., Ambrose, C. M., Srinidhi, J., Anderson, M., Barnes, G. T., Gusella, J. F., & MacDonald, M. E. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0018 · Cited by 82
Bartzokis, G., Lu, P. H., & Mintz, J. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6s604 · Cited by 81
Self-citationSchwob, V. S., Clark, H. B., Agrawal, D., & Agrawal, H. C. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb04024.x · Cited by 63
The Role of Metal Ions in Oxidative Processes and Aging
Floyd, R. A., & Carney, J. M. (1993) · Toxicology and Industrial Health · doi:10.1177/0748233793009001-214 · Cited by 58
OʼKusky, J. R., & Colonnier, M. (1982) · The Journal of Comparative Neurology · doi:10.1002/cne.902100309 · Cited by 57
Flaherty, L. T. (2013) · Routledge eBooks · doi:10.4324/9780203780589-9 · Cited by 49
Basics of Magnetic Resonance Imaging
Oldendorf, W. H., & Oldendorf, W. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-2081-4 · Cited by 45
Gruñeiro‐Papendieck, L., Chiesa, A. E., Martínez, A. S., Heinrich, J. J., & Bergadá, C. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023286 · Cited by 42
Ferritin levels in microglia depend upon activation: Modulation by reactive oxygen species
Mehlhase, J., Gieche, J., Widmer, R., & Grune, T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.012 · Cited by 38
The distribution of iron in the brain: A phylogenetic analysis using iron histochemistry
Erb, G. L., Osterbur, D., & LeVine, S. M. (1996) · Developmental Brain Research · doi:10.1016/0165-3806(96)00020-x · Cited by 35
Effects of diet and development upon the uptake and distribution of cerebral iron
Dwork, A. J. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00207-i · Cited by 35
Regional studies of myelin proteins in human brain and spinal cord
Trotter, J. L., Wegescheide, C. L., & Garvey, W. F. (1984) · Neurochemical Research · doi:10.1007/bf00967665 · Cited by 15
Age-Related Changes in Frontal and Temporal Lobe Volumes in Men: A Magnetic Resonance Imaging Study
Bartzokis, G., Beckson, M., Lu, P. H., Nuechterlein, K. H., Edwards, N., & Mintz, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.461 · Cited by 14
Self-citation
Flagged first, then by citations
1 of the 94 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Harper PS, Shaw D (1996) Huntington’s disease: genetic and molecular studies. In: Harper PS (eds) Huntington’s disease 2nd edn. W.B.Saunders, Philadelphia, pp 241–293
- Jones AL (1996) The Huntington’s disease gene and its protein product. In: Harper PS (eds) Huntington’s disease, 2 edn. W.B.Saunders, Philadelphia, pp 293–316
- Bruyn GW (1973) Neuropathological changes in Huntington’s chorea. In: Barbeau A, Chase TN, Paulson GW (eds) Huntington’s Chorea, vol 1. Raven Press, New York, pp 399–403
- Liss L, Paulson GW, Sommer A (1973) Rigid form of Huntington’s chorea: a clinicopathological study of three cases. In: Barbeau A, Chase TN, Paulson GW (eds) Huntington’s Chorea, vol 1. Raven Press, New York, pp 405–424
- Klintworth GK (1973) Huntington’s chorea—morphologic contributions of a century. In: Barbeau A, Paulson GW, Chase TN (eds) Advances in neurology. Huntington’s chorea, vol 1. 1872–1972. Raven Press, New York, pp 353–368
Cited by
Sorted by citations
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Oligodendrocytes and myelination: The role of iron
Todorich, B., Pasquini, J. M., Garcia, C. I., Paez, P. M., & Connor, J. R. (2008) · Glia · doi:10.1002/glia.20784 · Cited by 615
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 594
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
Self-citationMRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping
Bilgic, B., Pfefferbaum, A., Rohlfing, T., Sullivan, E. V., & Adalsteinsson, E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.077 · Cited by 499
Metadata
- Authors
- Bartzokis, G., Lu, P. H., Tishler, T. A., Fong, S. M., Oluwadara, B., Finn, J. P., Huang, D., Bordelon, Y., Mintz, J., & Perlman, S.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Bartzokis, George
- Venue
- Neurochemical Research
- Published
- 2007-05-05
- Volume
- 32
- Issue
- 10
- Pages
- 1655-1664
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W1986646115
- Cited by
- 238
- References
- 94
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 9 · 2023: 10 · 2022: 14 · 2021: 14 · 2020: 11 · 2019: 14 · 2018: 14 · 2017: 10 · 2016: 9 · 2015: 24 · 2014: 16 · 2013: 18 · 2012: 18
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health (5r03mh051928-02)
- National Institute on Aging (R01AG027342, P50AG016570, AG 16570)
- National Institute of Mental Health (MH6357-01A1, MH 51928, MH066029-01A2, R01MH066029)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- Huntington's disease, myelin breakdown, tissue integrity, remyelination, oligodendrocytes, striatum, corpus callosum, white matter, pathogenesis, preclinical disease, iron accumulation, MRI field strength
- MeSH terms
- Adult, Aged, Brain, Brain Chemistry, Data Interpretation, Statistical, Female, Ferritins, Humans, Huntington Disease, Image Processing, Computer-Assisted, Iron, Magnetic Resonance Imaging, Male, Middle Aged, Myelin Sheath
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review